Phenylboronic acid-functionalized BSA@CuS@PpIX nanoparticles for enhanced antibacterial photodynamic/photothermal therapy

Yun Liu,Qian Lan,Jinxiu Liu,Yaxin Shi,Quanxin Wu,Qian Wang,Shuang Yang,Fan Cheng
DOI: https://doi.org/10.1016/j.jddst.2023.104965
IF: 5
2023-09-20
Journal of Drug Delivery Science and Technology
Abstract:To avoid the occurrence of antibiotic resistance and improve bactericidal effect, a multifunctional antibacterial nanoagent BCPP was successfully constructed for targeted photodynamic/photothermal combination therapy (PDT/PTT). The prepared BCPP consist of protoporphyrin (PpIX) as the photosensitizer, CuS nanoparticles as the photothermal agent, phenylboric acid (PBA) as the bacteria-targeting segment and bovine serum albumin (BSA) as the colloid stabilizer. Afterwards, its photodynamic/photothermal capacities, bacteria-targeting effect and bactericidal efficiency were intensively investigated. Experimental results confirmed its good singlet oxygen generation ability and high photothermal conversion efficiency. In addition, BCPP displayed good bacteria-targeting properties for both S. aureus and E. coli . Moreover, in vitro antibacterial assays proved its enhanced therapeutic efficiency through combined antibacterial PDT/PTT owing to PBA-mediated bacteria-targeting function. Finally, in vitro assays revealed its good hemocompatibility and low cytotoxicity. To sum up, our study offered a convenient method to build non-antibiotic antibacterial nanoagents for targeted PDT/PTT, and the prepared bactericidal is a promising drug candidate suitable for clinical trials in the future. Graphical abstract A bacteria-targeting nanoplatform with enhanced therapeutic efficiency was developed for combined photodynamic/photothermal therapy. Download : Download high-res image (273KB) Download : Download full-size image
pharmacology & pharmacy
What problem does this paper attempt to address?